Bindarit, CCL2, CCL7 and CCL8 inhibitor from Abcam

Product Specs
ItemBindarit, CCL2, CCL7 and CCL8 inhibitor
CompanyAbcam
Price Supplier Page View Company Product Page
Catalog Numberab143292
Quantity5 mg, 25 mg, 50 mg
Purity0.99
TypeInhibitor, inhibitor
Molecule NameBindarit

Add to Compare List

Abcam

Discovery Drive

Cambridge Biomedical Campus

Cambridge CB2 0AX

United Kingdom

Phone: +44 (0) 1223 696000 (option 1)
+44 (0) 1223 696000 (option 2)
+44 (0) 1223 771600

Company Profile

Website: http://www.abcam.com

(1) Complex Interplay of Genes Underlies Invasiveness in Fibrosarcoma Progression ModelJournal of Clinical MedicineMay 25, 2021Michaela Kripnerová et al.to test consequences of pharmacologic inhibition of both the ligand CCL8 by Bindarit [40,41] (Abcam ab143292) and of its major receptor CCR5 by Maraviroc [42,43] (Sigma, Prague, CZ), either individually or in

(2) 15-Lipoxygenase and 15-hydroxyeicosatetraenoic acid regulate intravascular thrombosis in pulmonary hypertensionAmerican journal of physiology. Lung cellular and molecular physiologySeptember 1, 2015Shen T, Shi J, Wang N, Yu X, Zhang C, Li J, Wei L, Ma C, Zhao X, Lian M, et al.mg/kg body wt, orally once daily, for 11 days) (2, 15) or MCP-1 synthesis inhibitor bindarit (Abcam, ab143292, 100 mg/kg body wt, orally once daily, for 11 days) (42) from 2 days before hypoxia till they were anesthetized. Adult

Be the First to Write a Review!

Bindarit, CCL2, CCL7 and CCL8 inhibitor from Abcam

Description

Abcam

Citations (2)

Reviews

Bindarit, CCL2, CCL7 and CCL8 inhibitor from Abcam

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map